137 related articles for article (PubMed ID: 38606828)
1. Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer.
Lee YY; Chen YL; Lai YL
J Gynecol Oncol; 2024 May; 35(3):e88. PubMed ID: 38606828
[No Abstract] [Full Text] [Related]
2. Response to: Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer.
Akgor U; Ozgul N; Ayhan A
J Gynecol Oncol; 2024 May; 35(3):e92. PubMed ID: 38616118
[No Abstract] [Full Text] [Related]
3. Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer.
Akgor U
J Gynecol Oncol; 2024 May; 35(3):e89. PubMed ID: 38606829
[No Abstract] [Full Text] [Related]
4. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan.
Lee YY; Lai YL; Kim MS; Chang K; Kim HS; Cheng WF; Chen YL
J Gynecol Oncol; 2024 May; 35(3):e33. PubMed ID: 38130137
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
7. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
[TBL] [Abstract][Full Text] [Related]
9. Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy.
Cahan B; Kim JH; Schultheiss TE; Wong JYC; Chen YJ
Am J Clin Oncol; 2018 Mar; 41(3):302-306. PubMed ID: 26886945
[TBL] [Abstract][Full Text] [Related]
10. Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer.
Nakayama K; Nagai Y; Ishikawa M; Aoki Y; Miyazaki K
Int J Clin Oncol; 2010 Oct; 15(5):440-6. PubMed ID: 20419386
[TBL] [Abstract][Full Text] [Related]
11. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Forsse D; Berg HF; Bozickovic O; Engerud H; Halle MK; Hoivik EA; Woie K; Werner HMJ; Haldorsen IS; Trovik J; Krakstad C
Gynecol Oncol; 2021 Feb; 160(2):396-404. PubMed ID: 33317908
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant postoperative treatment of endometrial cancer].
Vergote IB
Gynakologe; 1994 Apr; 27(2):84-8. PubMed ID: 8039747
[No Abstract] [Full Text] [Related]
13. A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer.
Todo Y; Kato H; Minobe S; Okamoto K; Suzuki Y; Konno Y; Takeda M; Watari H; Kaneuchi M; Sakuragi N
Gynecol Oncol; 2011 Apr; 121(1):126-30. PubMed ID: 21194738
[TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinoma: clinical characteristic and survival rates by the new compared to the prior FIGO staging systems.
Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Khunnarong J; Pataradool K; Thavaramara T
J Med Assoc Thai; 2013 May; 96(5):505-12. PubMed ID: 23745302
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
16. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
17. [Long-time survival cases of endometrial cancer].
Kato H; Shimizu M; Yamada T; Saji H; Sugiura K; Onose R; Nakayama H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():418-21. PubMed ID: 15535280
[No Abstract] [Full Text] [Related]
18. Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?
Marnitz S; Köhler C; Gharbi N; Kunze S; Jablonska K; Herter J
Strahlenther Onkol; 2018 Nov; 194(11):965-974. PubMed ID: 30112692
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary study of sequential multi-modality adjuvant chemotherapy and radiation for advanced endometrial cancer].
Zhang G; Suo HY; Shen XY; Zhao LJ; Wang ZQ; Kong WM; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 Feb; 54(2):103-109. PubMed ID: 30803169
[No Abstract] [Full Text] [Related]
20. Outcomes of stage II endometrial cancer: The UPMC Hillman Cancer Center experience.
Chen KS; Berhane H; Gill BS; Olawaiye A; Sukumvanich P; Kelley JL; Boisen MM; Courtney-Brooks M; Comerci JT; Edwards R; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):315-319. PubMed ID: 28866431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
